Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Swiss startup Enzian Pharmaceutics is developing a new tablet aimed at enhancing effectiveness and reducing side effects in cancer therapies

The capsules and tablets commonly used today consist of loose or lightly compressed particles of the drug and excipients. After ingestion, they disintegrate almost immediately in the stomach. The small drug particles then flow from the stomach and...

ChromaDex expands its pharmaceutical-grade Niagen® IV and injection offerings to more leading wellness clinics.

a focus on healthy aging, is excited to announce the second wave of intravenous (IV) wellness clinics that will offer pharmaceutical-grade Niagen® (nicotinamide riboside chloride or NRC), branded Niagen+, in intravenous (IV) and injectable forms....

Zydus announces an exclusive licensing and supply agreement for two Gadolinium-based MRI injectable contrast agents in the U.S

subsidiary, Zydus Lifesciences Global FZE has entered into an exclusive licensing and supply agreement with Viwit Pharmaceuticals (Viwit), an innovation driven biopharmaceutical and healthcare company, for gadobutrol injection (generic version of...

City of Hope and BRC treat first patient with BRC-001 in a breast cancer care trial.

City of Hope®, one of the largest cancer research and treatment organizations in the United States, and Biopharmaceutical Research Company (BRC), a specialty pharmaceutical company developing proprietary cannabinoid therapeutics, announced that...

Bloomage 2024 Mid-Year Report: International raw material sales exceed domestic Chinese market sales for the first time

global customers. Today, Bloomage's raw materials are integral to the product lines of numerous well-established pharmaceutical, personal care, and health food companies worldwide. "2024 is a year of success for Bloomage as our international market...

Solu Therapeutics appoints Sergio Santillana, MD, as Chief Medical Officer to strengthen its leadership team.

and Japan. In his career, Dr. Santillana has held the role of Chief Medical Officer at Ikena Oncology, Merrimack Pharmaceuticals and Ariad Pharmaceuticals, and had various leadership roles at Eli Lilly, GlaxoSmithKline and Takeda Pharmaceuticals....

Aptar Pharma signs an exclusive agreement with Pulmotree to develop and promote the Kolibri™ non-propellant liquid inhaler platform

from formulation development to patient onboarding.” Ulf Krüger, CEO of PULMOTREE, stated, “With this alliance, pharmaceutical partners can access an unprecedented portfolio of services from Aptar Pharma as a single source, in the development of...

AISA Pharma receives FDA orphan drug designation for AISA-021, a treatment for systemic sclerosis

Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to AISA-021(cilnidipine), a fourth-generation calcium channel antagonist. Aisa is...

A. Menarini Diagnostics and Nucleix announce a strategic partnership for a non-invasive bladder cancer test in Europe

quality of life of people all over the world. A. Menarini Diagnostics is part of the Menarini Group, a multinational pharmaceutical, biotechnology and diagnostics company headquartered in Florence, Italy, with more than 17,000 employees in 140...

IKA introduces new accessories for the HABITAT research bioreactor.

dedicated to advancing scientific research and industrial applications. Serving industries such as life sciences, pharmaceuticals, and chemicals, we help drive progress and improve lives. With over 900 employees at 16 locations on four continents,...

Corundum Systems Biology appoints Jessica Schneider as Chief Scientific Officer

where she managed investment in novel therapeutic modality platforms, having previously served as Director of Takeda Pharmaceuticals' Gastroenterology Drug Discovery Unit where she helped build the microbiome therapeutics portfolio spanning...

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

the company’s Life Science business achieved EXCiPACT cGMP (current Good Manufacturing Practice) certification for Pharmaceutical Auxiliary Materials (PAMs) at its major global Cell Culture Media (CCM) production sites. EXCiPACT is a widely...

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

future opportunities.” About Cygnus Technologies, LLC: Cygnus Technologies, part of Maravai LifeSciences, is the biopharmaceutical industry’s partner in host cell protein (HCP) and other process-related impurity detection and analytics as well as...

Find Therapeutics announces FDA clearance of its IND application for a Phase 1 study of FTX-101 to treat chronic optic neuropathy

Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, announced that the U.S. Food and Drug Administration ("FDA") has cleared its Investigational New Drug ("IND")...

Trinity Life Sciences introduces new customer engagement solutions, leveraging its deep commercial insight and renowned technology platform

and in major markets across specialty and primary care. Ms. Phelan also currently sits on the boards of Medexus Pharmaceuticals and FemmePharma Consumer Healthcare. “I’m delighted to have such a passionate, data-driven expert leading one of our...

ImmPACT Bio announces FDA clearance of its IND application for CD19/CD20 bispecific CAR-T cell therapy in multiple sclerosis

ImmPACT Bio USA Inc.a clinical-stage biopharmaceutical company developing a new generation of cellular therapies that have the potential to bring transformational benefits to patients, announced the United States Food and Drug Administration (FDA)...

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

disease. We are committed to a future without liver disease. About Gilead Sciences: Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating...

Aptar’s Nasal Unidose System will deliver neffy® (epinephrine nasal spray), the first FDA-approved needle-free treatment for Type I allergic reactions, including anaphylaxis

manufactured with strict quality controls intended to meet FDA’s guidelines for reliability. They offer biotech and pharmaceutical companies effective and reliable single or two-shot intranasal delivery for a variety of medicines including for...

Derm-Biome Pharmaceuticals to develop skincare treatment that promotes skin health and longevity

Derm-Biome Pharmaceuticals Inc, a Vancouver-based biopharmaceutical company focused on skin health and healthy aging, is excited to announce the development of a novel, science-backed skincare treatment aimed at targeting some of the root causes...

Spencer Trask & Co. launches Signal12 for Dry Eye Disease treatment, led by former Aerie executives, advancing Pro-ocular through trials

Signal12 as president and chief executive officer. Mitro is the former president and chief operating officer of Aerie Pharmaceuticals, where he grew annual sales to more than $100 million and facilitated a $770 million acquisition by Swiss eye-care...